[1]
“Targeted Nano-Encapsulated Ceftriaxone: Ligand–Receptor Interactions and Strategies to Overcome Efflux Pump-Mediated Resistance”, Pjmcr, vol. 5, no. 1, pp. 5711–5750, Mar. 2026, doi: 10.5281/zenodo.21921749.